Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.
How has the huoxiang zhengqi for covid 19 market size changed in recent years, and what is the outlook ahead?
The huoxiang zhengqi for COVID-19 market size has grown rapidly in recent years. It will grow from $1.38 billion in 2024 to $1.55 billion in 2025 at a compound annual growth rate (CAGR) of 12.8%. The growth in the historic period can be attributed to increasing demand for traditional Chinese medicine, increasing public awareness of natural remedies, rising cases of gastrointestinal symptoms, increasing demand for immune-boosting products, and a rising number of COVID-19 cases.
The huoxiang zhengqi for COVID-19 market size is expected to see rapid growth in the next few years. It will grow to $2.48 billion in 2029 at a compound annual growth rate (CAGR) of 12.4%. The growth in the forecast period can be attributed to the rising popularity of immune health supplements, the rising trend of self-medication for minor health issues, the increasing demand for non-pharmaceutical interventions, the growing accessibility of traditional Chinese medicine products online, and the rising demand for personalized health solutions. Major trends in the forecast period include technology-assisted remote diagnosis, developing new dosage forms, developing synergistic formulations, integration into telehealth platforms, and integration with hospital COVID-19 treatment guidelines.
Download Your Free Sample PDF:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24246&type=smp
What are the top economic and technological drivers pushing huoxiang zhengqi for covid 19 market growth?
The rising demand for traditional Chinese medicines is expected to propel the growth of the Huoxiang Zhengqi for COVID-19 market going forward. Traditional Chinese medicine (TCM) is an ancient system of healing that uses herbal remedies, acupuncture, massage, and dietary therapy to balance the body’s energy, promote healing, and prevent illness. The rising demand for traditional Chinese medicines is primarily driven by the growing interest in natural and herbal remedies as consumers seek alternative, holistic approaches to health and wellness. Huoxiang Zhengqi for COVID-19 enhances traditional Chinese medicine by offering a therapeutic approach that integrates herbal ingredients known for their ability to balance the body’s immune response and alleviate symptoms associated with viral infections. For instance, in January 2025, according to the report published by the National Library of Medicine, a US-based biomedical library, in 2023, the export value of traditional Chinese medicine (TCM) including both medicinal materials and plant extracts reached $1.933 billion. Therefore, the rising demand for traditional Chinese medicines is driving the growth of the Huoxiang Zhengqi for COVID-19 market.
Increasing Demand For Herbal Medicine Fueling The Growth Of The Market Due To Consumer Preference For Natural Remedies
The increasing demand for herbal medicine is expected to propel the growth of the Huoxiang Zhengqi for COVID-19 market going forward. Herbal medicine refers to the use of plants or plant-derived substances for therapeutic or medicinal purposes to prevent, treat, or manage health conditions. The rising demand for herbal medicine is mainly driven by consumers’ growing preference for natural, plant-based remedies over synthetic drugs due to perceived safety, fewer side effects, and holistic health benefits. Huoxiang Zhengqi for COVID-19 aids herbal medicine by providing a traditional remedy that supports immune function, alleviates symptoms, and promotes recovery, demonstrating the potential role of herbal therapies in managing viral infections. For instance, in September 2024, according to the HerbalGram, a US-based nonprofit organization, the total annual sales of herbal dietary supplements rose from $12.018 billion in 2022 to $12.551 billion in 2023, reflecting a growth of 4.4%. Therefore, the increasing demand for herbal medicine is driving the growth of the Huoxiang Zhengqi for COVID-19 market.
Increasing Incidence Of Respiratory Diseases Fueling The Growth Of The Market Due To Increasing Respiratory Illnesses And Viral Infections
The increasing incidence of respiratory diseases is expected to propel the growth of Huoxiang Zhengqi for COVID-19 market going forward. Respiratory diseases refer to any condition that affects the lungs and other parts of the respiratory system, leading to difficulty in breathing or impaired lung function. The rise in respiratory diseases is due to rising air pollution, which increases the exposure to harmful pollutants that irritate the airways and worsen lung function. Huoxiang Zhengqi for COVID-19 supports respiratory disease treatment by addressing symptoms linked to dampness and digestive imbalance, which are common in respiratory infections. It aids recovery by alleviating nausea, chest congestion, and fatigue, thereby enhancing overall resilience during mild respiratory illnesses. For instance, in April 2024, according to the Australian Bureau of Statistics, an Australian-based government agency, there were 361 deaths due to acute respiratory infections in 2023, up from 241 deaths in 2022. Therefore, the increasing incidence of respiratory diseases is driving the growth of the Huoxiang Zhengqi for COVID-19 market.
How is the huoxiang zhengqi for covid 19 market segmented by product, application, and end-user?
The huoxiang zhengqi for covid 19 market covered in this report is segmented –
1) By Product Type: Liquid, Pills, Granules, Other Product Types
2) By Consumers: Health-Conscious Consumers, Individuals Seeking Immunity Support, Alternative Medicine Enthusiasts, Parents Purchasing For Children
3) By Usage Occasions: Preventive Health Use, During COVID 19 Symptoms, Post-Recovery Health Management, Seasonal Illness Protection
4) By Application: Hospitals, Clinics, Home Care, Other Applications
5) By Distribution Chanel, Online Pharmacies, Retail Pharmacies, Hospital Pharmacies, Other Distribution Chanels
Subsegments:
1) By Liquid: Oral Liquid, Injectable Liquid
2) By Pills: Tablets, Capsules
3) By Granules: Single-Dose Granules, Multi-Dose Granules
4) By Other Product Types: Syrup, Powder For Solution
View The Full Market Report:
https://www.thebusinessresearchcompany.com/report/huoxiang-zhengqi-for-covid-19-global-market-report
Which leading companies are dominating the huoxiang zhengqi for covid 19 market landscape?
Major companies operating in the huoxiang zhengqi for covid 19 market are Yunnan Baiyao Group Co. Ltd., Beijing Tongrentang Co. Ltd., Taiji Group Chongqing Fuling Pharmaceutical Factory Co. Ltd, Zhangzhou Pientzehuang Pharmaceutical Co. Ltd, Tasly Pharmaceutical Group Co. Ltd., Harbin Pharmaceutical Group Co. Ltd., Guizhou Sanli Pharmaceutical Co. Ltd, China Shineway Pharmaceutical Group Limited, Hubei University of Chinese Medicine, Beijing University of Chinese Medicine, Wuhu Zhanghengchun Medicine Co. Ltd.
Which geographic areas are expected to offer the highest growth opportunities in thehuoxiang zhengqi for covid 19 market?
Asia-Pacific was the largest region in the Huoxiang Zhengqi for COVID-19 market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the huoxiang zhengqi for covid 19 market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Can Companies Use The Huoxiang Zhengqi For Covid 19 Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.
Purchase The Report And Get A Swift Delivery:
https://www.thebusinessresearchcompany.com/customise?id=24246&type=smp
Need Customized Data On Huoxiang Zhengqi For Covid 19 Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
Request Customized Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24246&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
